Diagnostic Validity Ofclinical Tests for Infrapatellar Fat Pad Impingement Syndrome
ETICHOFFA
Diagnostic Validity of Infrapatellar Fat Pad Impingement Syndrome: Performance of Clinical Tests Compared to MRI Imaging
2 other identifiers
observational
50
1 country
1
Brief Summary
The ETICHOFFA study is a clinical research project aiming to improve the diagnosis of Infrapatellar fat pad impingement syndrome, a common source of anterior knee pain. Although MRI remains the gold standard for diagnosis, clinical testing strategies lack validation. This observational study has two main objectives: to assess the diagnostic accuracy of a cluster of standardized clinical provocation tests for IFP impingement compared to MRI findings, and to identify clinical and subjective characteristics associated with IFP involvement confirmed by imaging. This observational study will recruit 50 patients aged 18 to 70 years with anterior knee pain rated at least 3 out of 10 in intensity. Participants will complete a secure online questionnaire documenting symptoms, pain distribution, aggravating and relieving factors, and pain intensity at rest, during activity, and daily life. They will also complete three validated scales: the Anterior Knee Pain Scale (AKPS), the Knee injury and Osteoarthritis Outcome Score (KOOS), and the Tampa Scale for Kinesiophobia (TSK). A standardized clinical examination will be performed, including subpatellar skin temperature measurement, knee swelling assessment, passive range of motion testing, and a series of provocation tests targeting Hoffa's fat pad. Tests will be randomized to reduce bias and considered positive if they reproduce the patient's typical pain with an intensity of at least 2/10. Each participant must also undergo a standardized MRI of the knee within two weeks of the clinical assessment, interpreted blindly by an independent musculoskeletal radiologist. All data will be anonymized, stored securely, and analyzed using SPSS software. Diagnostic accuracy of clinical tests will be evaluated through sensitivity, specificity, predictive values, and likelihood ratios. Functional outcomes related to taping will also be analyzed. The study has received ethical approval and adheres to GDPR standards for data protection. Participation is voluntary, with the right to withdraw at any time. The ETICHOFFA study is expected to enhance clinical diagnostic pathways for anterior knee pain associated with Infrapatellar fat pad involvement.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jun 2025
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 28, 2025
CompletedFirst Posted
Study publicly available on registry
May 14, 2025
CompletedStudy Start
First participant enrolled
June 17, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 28, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2026
ExpectedFebruary 20, 2026
May 1, 2025
4 months
April 28, 2025
February 18, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The primary endpoint of this study is the diagnostic value of the five clinical tests targeting the infrapatellar fat pad, considered collectively as a test cluster.
The overall performance of the test cluster will be analyzed using contingency matrices comparing the combined clinical test results with MRI findings. Various combination strategies will be tested (e.g., ≥2 positive tests out of 5), and the following diagnostic validity indices will be calculated for each threshold: sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and positive and negative likelihood ratios (LR⁺, LR-). ROC curves will be generated, and the area under the curve (AUC) will be used as a synthetic indicator of the cluster's discriminative capacity, with an AUC ≥ 0.80 considered clinically meaningful.
At baseline (post-imaging and clinical assessment)
Secondary Outcomes (13)
Diagnostic performance of individual clinical tests
At baseline (post clinical assessment)
Post-test probability of Infrapatellar fat pad impingement (Fagan nomogram analysis)
At baseline (post-imaging and clinical assessment)
Infrapatellar skin temperature at rest (lying position)
At baseline (during initial clinical assessment)
Presence of intra-articular swelling (Stroke Test)
At baseline (during initial clinical assessment)
Passive range of motion of the knee (flexion and extension)
At baseline (during initial clinical assessment)
- +8 more secondary outcomes
Interventions
The clinical evaluation specific to Infrapatellar fat pad is based on a series of five standardized clinical tests, extensively described in the specialized literature: provoked palpation of the fat pad, provoked passive extension, Hoffa's test, gliding test, and provoked passive flexion. These tests are performed in a randomized order to limit sequence bias. A test is considered positive if it reproduces the patient's typical anterior knee pain with an intensity greater than 2/10 on the numerical pain scale. Although widely used, these tests have not yet undergone rigorous methodological validation, which this study specifically aims to address.
Eligibility Criteria
Adults aged 18 to 70 years experiencing anterior knee pain (AKP) rated ≥3/10 for at least 4 weeks will be eligible. Patients will be recruited from the department of orthopedic and trauma at Hôpital Paris-Est Val de Marne (Saint-Maurice), including both postoperative cases (e.g., post-arthroscopy) and non-surgical patients referred for expert consultation regarding persistent or unexplained anterior knee pain.
You may qualify if:
- Age between 18 and 70 years
- Presence of anterior knee pain with an intensity of ≥3/10 on the Numerical Rating Scale (NRS), on most days over the past month
- MRI of the knee performed within a maximum of 15 days before or after the clinical examination.
You may not qualify if:
- History of corticosteroid injection treatment within the previous 12 months;
- Known allergy or skin intolerance to medical adhesives or rigid tape;
- History of hip or lumbar spine surgery;
- History of neurological disorders or a diagnosis of fibromyalgia;
- Contraindication to MRI (e.g., metallic foreign body, incompatible implantable device)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hôpitaux Paris Est Val-de-Marne - Service de rééducation orthopédique et traumatologie
Saint-Maurice, 94410, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 28, 2025
First Posted
May 14, 2025
Study Start
June 17, 2025
Primary Completion
October 28, 2025
Study Completion (Estimated)
June 1, 2026
Last Updated
February 20, 2026
Record last verified: 2025-05